# Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

> **NCT04884685** · PHASE2 · COMPLETED · sponsor: **Sinovac Life Sciences Co., Ltd.** · enrollment: 500 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 Inactivated Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04884685
- **Lead sponsor:** Sinovac Life Sciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2021-08-01
- **Final completion:** 2022-06-20
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884685, "Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04884685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*